Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth

Hugo A Acosta-Jaquez1, Jennifer A Keller, Kathryn G Foster

  • 1Department of Cell and Developmental Biology, University of Michigan Medical School, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA.

Insights

New research reveals that mammalian target of rapamycin (mTOR) phosphorylation at S1261 is crucial for mTOR complex 1 (mTORC1) signaling, promoting cell growth and substrate phosphorylation.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is a critical regulator of cell growth, responding to environmental cues like growth factors and nutrients.
  • The precise biochemical mechanisms governing mTORC1 signaling and the functional significance of mTOR phosphorylation sites remain incompletely understood.

Purpose of the Study:

  • To identify and functionally characterize novel phosphorylation sites on mTOR.
  • To elucidate the role of mTOR phosphorylation at serine 1261 (S1261) in regulating mTORC1 activity and cellular biosynthesis.

Main Methods:

  • Tandem mass spectrometry was employed to identify new mTOR phosphorylation sites.
  • Experiments involved manipulating insulin-phosphatidylinositol 3-kinase (PI3K) and TSC/Rheb signaling pathways.
  • Western blotting and cell size measurements were used to assess mTORC1 activity and cell growth.

Main Results:

  • A novel mTOR phosphorylation site, S1261, was identified and shown to be regulated by insulin-PI3K and TSC/Rheb signaling in an amino acid-dependent and rapamycin-insensitive manner.
  • Phosphorylation of mTOR at S1261 was demonstrated to be essential for mTORC1-mediated phosphorylation of substrates like S6K1 and 4E-BP1, and for promoting cell growth.
  • mTOR S1261 phosphorylation is required for Rheb-driven mTOR S2481 autophosphorylation and subsequent S6K1 phosphorylation.

Conclusions:

  • Site-specific phosphorylation of mTOR at S1261 is a key regulatory mechanism controlling mTORC1 function.
  • Insulin-stimulated mTOR S1261 phosphorylation enhances mTORC1 autokinase activity, leading to increased substrate phosphorylation and cell growth.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...